What does CUSIP 590328AA8 represent in this 13F holders report?

CUSIP 590328AA8 is the security identifier for 590328AA8 - MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 used to aggregate holder disclosures.

How many institutions held 590328AA8 - MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 in Q3 2020?

No institutional holders were reported for 590328AA8 - MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 in Q3 2020; review adjacent reporting periods for trend context.

MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1

CUSIP: 590328AA8

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Debt / NOTE 4.500% 7/1
Total 13F principal: $0
Principal change: -$26,000
Total reported market value: $0
Number of holders: 0
Value change: -$24,000
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 590328AA8?
CUSIP 590328AA8 identifies 590328AA8 - MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2020

Recent filing periods for CUSIP 590328AA8:

Q3 2020 Q2 2020 Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019 Q4 2018

MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1

Q3 2020 13F Holders as of 30 Sep 2020

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q3 2020.